Galectin-7 Expression in the Placentas of Women with Gestational Diabetes Mellitus
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms251810186 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Christina Teresa Seifert und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University Hospital, LMU Munich, 81377 Munich, Germany. Hauptthemen laut MEDLINE: Diabetes, Gestational, Galectins, Placenta. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Gestational diabetes mellitus (GDM) is a common condition during pregnancy. The prevalence of GDM is continuously increasing worldwide. Due to accessible diagnostic methods and a clear understanding of risk factors, GDM can be effectively diagnosed and managed. Galectins may influence immunomodulatory and inflammatory processes. This study examines the expression of galectin-7 in the placentas of women with gestational diabetes (GDM), compares it to its expression in healthy pregnancies, and evaluates the associated clinical outcomes. The placentas of 40 healthy women and 40 GDM placentas were included in the cohort. The expression level of galecin-7 was measured in the syncytiotrophoblast (SCT) and in the decidua of the placenta by immunohistochemistry and double immunofluorescence staining. The evaluation was performed by an immunoreactivity score (IRS). The study results show an increased expression of galectin-7 in the SCT and the decidua of GDM placentas as compared to the placentas of the control group. Elevated levels of galectin-7 were observed in both the nucleus and the cytoplasm. This study investigated the hypothesis that galectins are involved in pathophysiological processes of gestational diabetes. Statistical analysis of gene expression patterns confirmed that galectin-7 is indeed upregulated in GDM placentas. Further studies are needed to show the correlation of galectin-7 and the development and maintenance of gestational diabetes mellitus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, University Hospital, LMU Munich, 81377 Munich, Germany.
- Department of Pathology, University Hospital, LMU Munich, 81377 Munich, Germany.
- Department of Obstetrics and Gynecology, University Hospital Augsburg, 86156 Augsburg, Germany.
ORCID-Profile: Christina Teresa Seifert, Udo Jeschke, Thomas Kolben
Zitieren
APA
Seifert, C. T., Unverdorben, L., Knabl, J., Hutter, S., Keckstein, S., Schmoeckel, E., Kessler, M., Jeschke, U., Mahner, S., Kolben, T., & Ganster, F. (2024). Galectin-7 Expression in the Placentas of Women with Gestational Diabetes Mellitus. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251810186
Vancouver
Seifert CT, Unverdorben L, Knabl J, Hutter S, Keckstein S, Schmoeckel E, et al. Galectin-7 Expression in the Placentas of Women with Gestational Diabetes Mellitus. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251810186
BibTeX
@article{Seifert2024,
author = {Seifert, Christina Teresa and Unverdorben, Laura and Knabl, Julia and Hutter, Stefan and Keckstein, Simon and Schmoeckel, Elisa and Kessler, Mirjana and Jeschke, Udo and Mahner, Sven and Kolben, Thomas and Ganster, Franziska},
title = {Galectin-7 Expression in the Placentas of Women with Gestational Diabetes Mellitus},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms251810186}
}
EUVIMED